Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study
- PMID: 18208889
- DOI: 10.1177/1352458507084650
Factors predicting incomplete recovery from relapses in multiple sclerosis: a prospective study
Abstract
Objective: To prospectively evaluate predictors of incomplete recovery after the first attacks in a cohort of patients with clinically isolated syndrome or relapsing-remitting multiple sclerosis.
Methods: Seventy-two consecutive patients recruited from January 2001 to December 2003, evaluated every six months or at any relapse up to 31 July 2005. Relapse intervals were calculated from the date of onset, nadir, onset of improvement and maximum improvement. Predictive factors analysed were relapse-related (age at relapse onset, season and severity of the relapse, type of symptoms, speed of onset, plateau and total duration, number of affected Functional systems, preceding infections) and individual-related (gender, age at first attack, season of birth and first attack, characteristics of first brain MRI and cerebrospinal fluid oligoclonal bands, Link Index, IgG).
Results: We counted 209 attacks: 44 (21%) left mild sequelae, and 27 (13%) severe. The highest probability of sequelae was associated with sphincteric symptoms (9/20; 45%), followed by sensitive (38/113; 34%), motor (20/84; 24%), visual (13/61; 21%), cerebellar (4/24; 17%), brainstem (5/44; 11%) and others (0/6) ( P 0.005). Four variables were still relevant to predict sequelae after multivariate analysis: mild, moderate or severe relapses versus very mild (Odds ratio = 17.2, 95% confidence limits = 2.2-136.4), intermediate or long relapses versus short (3.2, 1.5-6.9), age >or= 30 at relapse onset (2.9, 1.5-5.7) and bi-polysymptomatic versus monosymptomatic (2.2, 1.1-4.3).
Conclusions: Factors predicting incomplete recovery are more closely linked to the characteristics of the single relapse (extension and duration of tissue damage) than to the patient's genetic and environmental background.
Similar articles
-
Multiple sclerosis relapses: a multivariable analysis of residual disability determinants.Acta Neurol Scand. 2009 Feb;119(2):126-30. doi: 10.1111/j.1600-0404.2008.01076.x. Epub 2008 Aug 5. Acta Neurol Scand. 2009. PMID: 18684216
-
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?Neurology. 2008 Mar 25;70(13 Pt 2):1079-83. doi: 10.1212/01.wnl.0000280576.73609.c6. Epub 2007 Sep 19. Neurology. 2008. PMID: 17881717
-
Are initial demyelinating event recovery and time to second event under differential control?Neurology. 2006 Sep 12;67(5):809-13. doi: 10.1212/01.wnl.0000234031.30756.a0. Neurology. 2006. PMID: 16966542
-
The incomplete nature of multiple sclerosis relapse resolution.J Neurol Sci. 2007 May 15;256 Suppl 1:S14-8. doi: 10.1016/j.jns.2007.01.062. Epub 2007 Mar 2. J Neurol Sci. 2007. PMID: 17337274 Review.
-
The natural history of relapses in multiple sclerosis.J Neurol Sci. 2007 May 15;256 Suppl 1:S5-13. doi: 10.1016/j.jns.2007.01.065. Epub 2007 Mar 7. J Neurol Sci. 2007. PMID: 17346747 Review.
Cited by
-
Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs-A Systematic Review.J Clin Med. 2019 Oct 4;8(10):1623. doi: 10.3390/jcm8101623. J Clin Med. 2019. PMID: 31590282 Free PMC article. Review.
-
A Prospective Observational Registry of Repository Corticotropin Injection (Acthar® Gel) for the Treatment of Multiple Sclerosis Relapse.Front Neurol. 2020 Dec 22;11:598496. doi: 10.3389/fneur.2020.598496. eCollection 2020. Front Neurol. 2020. PMID: 33414758 Free PMC article.
-
Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability.Mult Scler J Exp Transl Clin. 2021 May 28;7(2):20552173211015503. doi: 10.1177/20552173211015503. eCollection 2021 Apr-Jun. Mult Scler J Exp Transl Clin. 2021. PMID: 34104471 Free PMC article.
-
Relapse recovery: The forgotten variable in multiple sclerosis clinical trials.Neurol Neuroimmunol Neuroinflamm. 2019 Dec 17;7(2):e653. doi: 10.1212/NXI.0000000000000653. Print 2020 Mar. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31848231 Free PMC article.
-
Predictors of severity and outcome of multiple sclerosis relapses.BMC Neurol. 2023 Feb 13;23(1):67. doi: 10.1186/s12883-023-03109-6. BMC Neurol. 2023. PMID: 36782141 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources